PureTech Health plc (PRTC)
NASDAQ: PRTC · Real-Time Price · USD
18.17
+0.67 (3.85%)
Aug 15, 2025, 10:32 AM - Market open
PureTech Health Employees
PureTech Health had 56 employees as of December 31, 2024. The number of employees decreased by 34 or -37.78% compared to the previous year.
Employees
56
Change (1Y)
-34
Growth (1Y)
-37.78%
Revenue / Employee
$86,214
Profits / Employee
$955,536
Market Cap
428.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 56 | -34 | -37.78% |
Dec 31, 2023 | 90 | -21 | -18.92% |
Dec 31, 2022 | 111 | 16 | 16.84% |
Dec 31, 2021 | 95 | -155 | -62.00% |
Dec 31, 2020 | 250 | -50 | -16.67% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
PRTC News
- 1 day ago - PureTech Founded Entity Vedanta Biosciences Announces Phase 2 Study of VE202 in Ulcerative Colitis Did Not Meet Primary Endpoint - Business Wire
- 3 days ago - PureTech Announces the Launch of Celea Therapeutics With a Mission to Transform the Treatment of Respiratory Diseases - Business Wire
- 4 weeks ago - PureTech Announces Leadership Transition - Business Wire
- 5 weeks ago - PureTech Announces Board Change - Business Wire
- 2 months ago - PureTech Health: Results of Annual General Meeting - Business Wire
- 3 months ago - PureTech to Present at the Jefferies Global Healthcare Conference - Business Wire
- 3 months ago - PureTech Announces Publication of New Research Highlighting Untold Experiences of People Living with Idiopathic Pulmonary Fibrosis (IPF) - Business Wire
- 3 months ago - PureTech to Present Results from Phase 2b ELEVATE IPF Trial of Deupirfenidone (LYT-100) at the American Thoracic Society International Conference - Business Wire